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Background
Generation of CD8 T cell responses following viral infec-
tion or vaccination is indispensable for infection control.
Regulatory CD4+ CD25+ T cells (Treg) are a key factor for
the inefficiency of CD8 responses in viral persistence. The
mechanisms of this suppression are not elucidated. Treg
constitutively express the ectonucleotidase CD39, that
generates immunosuppressive adenosine in the sites of
immune activation.
Methods
HIV+ patients either treated or not with antivirals (CD4
>350 cells/mkl, n = 47) were studied in parallel with HIV-
controls (n = 25). CD8 and Treg cells were purified by
magnetic beads separation. Anti-CD3 stimulated CD8 T
cell proliferation was assessed on CFSE-stained CD8 T
cells cultured in the presence of either: i) Treg preincu-
bated with anti-CD39 blocking mAb or isotype control; ii)
adenosine analogue CGS 21680. Expression of the adeno-
sine A2A receptor (A2AR) was quantified by RT-PCR.
Results
Treg – associated CD39 expression was significantly
increased in HIV+ patients as compared to HIV- controls
(mean CD39+ Treg %2.1 vs. 0.98 and mean CD39 MFI
1011 vs. 606, P < 0.01 for both). In the presence of Treg,
proliferation of HIV+ CD8 T cells was significantly inhib-
ited (mean inhibition 56% vs. 22.5% for HIV- controls; P
< 0.01), while the inhibition decreased to an average of
12.3% (P < 0.01) in the presence of anti-CD39 blocking
mAb. HIV+ CD8 T cells were characterized by an elevated
expression of A2AR. The inhibitory effect of Treg on HIV+
CD8 T cell proliferation was reproduced by adenosine
agonist. Finally, the percentage of Treg CD39+ was corre-
lated with plasma HIV RNA values in HIV+ treatment-
naive patients and inversely with CD4 AC.
Conclusion
Treg CD39-adenosinergic axis is involved in the progres-
sion of chronic HIV-1 infection and Treg-mediated inhibi-
tion of CD8 T cell proliferation. Modulation of Treg
CD39+ function might be an attractive approach for
enhancing CD8 T lymphocyte responses.
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